Abl interactor 1 regulates Src-Id1-matrix metalloproteinase 9 axis and is required for invadopodia formation, extracellular matrix degradation and tumor growth of human breast cancer cells

Carcinogenesis

Volumn 30, Issue 12, 2009, Pages 2109-2116

  Sun, Xiaolin ^a,b   Li, Chenghai ^a   Zhuang, Chunmei ^a,c   Gilmore, William C ^d   Cobos, Everardo ^a,e   Tao, Yunxia ^a   Dai, Zonghan ^a,e  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b CHINA AGRICULTURAL UNIVERSITY   (China)

^c SHANDONG UNIVERSITY   (China)

^d Texas Veterinary Medical Diagnostic Laboratory   (United States)

^e TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; SHORT HAIRPIN RNA; SRC INHIBITOR OF DIFFERENTIATION PROTEIN 1 MATRIX METALLOROTEINASE; STEROID RECEPTOR COACTIVATOR 1; UNCLASSIFIED DRUG; ABI1 PROTEIN, HUMAN; CYTOSKELETON PROTEIN; GELATINASE B; ID1 PROTEIN, HUMAN; INHIBITOR OF DIFFERENTIATION 1; PROTEIN TYROSINE KINASE; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; EPIGENETICS; GENE SILENCING; HUMAN; HUMAN CELL; INVADOPODIA; MIGRATION INHIBITION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; BIOLOGICAL MODEL; BREAST TUMOR; CANCER INVASION; CELL MOTION; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYTOSKELETAL PROTEINS; EPIGENESIS, GENETIC; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEIN 1; MATRIX METALLOPROTEINASE 9; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

EID: 73949116683     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp251     Document Type: Article

References (51)

1. Chen, W.T. (1989) Proteolytic activity of specialized surface protrusions formed at rosette contact sites of transformed cells. J. Exp. Zool., 251, 167-185.
2. Kelly, T. et al. (1994) Invadopodia promote proteolysis of a wide variety of extracellular matrix proteins. J. Cell. Physiol., 158, 299-308.
3. Buccione, R. et al. (2004) Foot and mouth: podosomes, invadopodia and circular dorsal ruffles. Nat. Rev. Mol. Cell. Biol., 5, 647-657.
4. Gimona, M. et al. (2008) Assembly and biological role of podosomes and invadopodia. Curr. Opin. Cell Biol., 20, 235-241.
5. Hashimoto, S. et al. (2004) Requirement for Arf6 in breast cancer invasive activities. Proc. Natl Acad. Sci. USA, 101, 6647-6652.
6. Onodera, Y. et al. (2005) Expression of AMAP1, an ArfGAP, provides novel targets to inhibit breast cancer invasive activities. EMBO J., 24, 963-973.
7. Seals, D.F. et al. (2005) The adaptor protein Tks5/Fish is required for podosome formation and function, and for the protease-driven invasion of cancer cells. Cancer Cell, 7, 155-165.
8. Nam, J.M. et al. (2007) CIN85, a Cbl-interacting protein, is a component of AMAP1-mediated breast cancer invasion machinery. EMBO J., 26, 647-656.
9. Badowski, C. et al. (2008) Paxillin phosphorylation controls invadopodia/podosomes spatiotemporal organization. Mol. Biol. Cell, 19, 633-645.
10. Marchisio, P.C. et al. (1988) Vinculin, talin, and integrins are localized at specific adhesion sites of malignant B lymphocytes. Blood, 72, 830-833.
11. Yamaguchi, H. et al. (2005) Molecular mechanisms of invadopodium formation: the role of the N-WASP-Arp2/3 complex pathway and cofilin. J. Cell Biol., 168, 441-452.
12. Nakahara, H. et al. (1997) Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion. Proc. Natl Acad. Sci. USA, 94, 7959-7964.
13. Bourguignon, L.Y. et al. (1998) CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells. J. Cell. Physiol., 176, 206-215.
14. Chen, W.T. et al. (1999) Specialized surface protrusions of invasive cells, invadopodia and lamellipodia, have differential MT1-MMP, MMP-2, and TIMP-2 localization. Ann. N.Y. Acad. Sci., 878, 361-371.
15. Artym, V.V. et al. (2006) Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function. Cancer Res., 66, 3034-3043.
16. Deryugina, E.I. et al. (2006) Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev., 25, 9-34.
17. Hauck, C.R. et al. (2002) v-Src SH3-enhanced interaction with focal adhesion kinase at beta 1 integrin-containing invadopodia promotes cell invasion. J. Biol. Chem., 277, 12487-12490.
18. Mizutani, K. et al. (2002) Essential role of neural Wiskott-Aldrich syndrome protein in podosome formation and degradation of extracellular matrix in src-transformed fibroblasts. Cancer Res., 62, 669-674.
19. Berdeaux, R.L. et al. (2004) Active Rho is localized to podosomes induced by oncogenic Src and is required for their assembly and function. J. Cell Biol., 166, 317-323.
20. Courtneidge, S.A. et al. (2005) The SRC substrate Tks5, podosomes (invadopodia), and cancer cell invasion. Cold Spring Harb. Symp. Quant. Biol., 70, 167-171.
21. Bharti, S. et al. (2007) Src-dependent phosphorylation of ASAP1 regulates podosomes. Mol. Cell. Biol., 27, 8271-8283.
22. Destaing, O. et al. (2008) The tyrosine kinase activity of c-Src regulates actin dynamics and organization of podosomes in osteoclasts. Mol. Biol. Cell, 19, 394-404.
23. Sikder, H.A. et al. (2003) Id proteins in cell growth and tumorigenesis. Cancer Cell, 3, 525-530.
24. Gautschi, O. et al. (2008) Regulation of Id1 expression by SRC: implications for targeting of the bone morphogenetic protein pathway in cancer. Cancer Res., 68, 2250-2258.
25. Nieborowska-Skorska, M. et al. (2006) Id1 transcription inhibitor-matrix metalloproteinase 9 axis enhances invasiveness of the breakpoint cluster region/abelson tyrosine kinase-transformed leukemia cells. Cancer Res., 66, 4108-4116.
26. Linder, S. et al. (1999) Wiskott-Aldrich syndrome protein regulates podosomes in primary human macrophages. Proc. Natl Acad. Sci. USA, 96, 9648-9653.
27. Bompard, G. et al. (2004) Regulation of WASP/WAVE proteins: making a long story short. J. Cell Biol., 166, 957-962.
28. Takenawa, T. et al. (2007) The WASP-WAVE protein network: connecting the membrane to the cytoskeleton. Nat. Rev. Mol. Cell Biol., 8, 37-48.
29. Innocenti, M. et al. (2005) Abi1 regulates the activity of N-WASP and WAVE in distinct actin-based processes. Nat. Cell Biol., 7, 969-976.
30. Eden, S. et al. (2002) Mechanism of regulation of WAVE1-induced actin nucleation by Rac1 and Nck. Nature, 418, 790-793.
31. Innocenti, M. et al. (2004) Abi1 is essential for the formation and activation of a WAVE2 signalling complex. Nat. Cell Biol., 6, 319-327.
32. Gautreau, A. et al. (2004) Purification and architecture of the ubiquitous Wave complex. Proc. Natl Acad. Sci. USA, 101, 4379-4383.
33. Innocenti, M. et al. (2003) Phosphoinositide 3-kinase activates Rac by entering in a complex with Eps8, Abi1, and Sos-1. J. Cell Biol., 160, 17-23.
34. Scita, G. et al. (1999) EPS8 and E3B1 transduce signals from Ras to Rac. Nature, 401, 290-293.
35. Innocenti, M. et al. (2002) Mechanisms through which Sos-1 coordinates the activation of Ras and Rac. J. Cell Biol., 156, 125-136.
36. Fan, P.D. et al. (2000) Abl interactor 1 binds to sos and inhibits epidermal growth factor-and v-Abl-induced activation of extracellular signalregulated kinases. Mol. Cell. Biol., 20, 7591-7601.
37. Leng, Y. et al. (2005) Abelson-interactor-1 promotes WAVE2 membrane translocation and Abelson-mediated tyrosine phosphorylation required for WAVE2 activation. Proc. Natl Acad. Sci. USA, 102, 1098-1103.
38. Dai, Z. et al. (1998) Oncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Rasindependent pathway. Genes Dev., 12, 1415-1424.
39. Taki, T. et al. (1998) ABI-1, a human homolog to mouse Abl-interactor 1, fuses the MLL gene in acute myeloid leukemia with t(10;11)(p11.2;q23). Blood, 92, 1125-1130.
40. Wang, C. et al. (2007) Abelson interactor protein-1 positively regulates breast cancer cell proliferation, migration, and invasion. Mol. Cancer Res., 5, 1031-1039.
41. Li, Y. et al. (2007) Bcr-Abl induces abnormal cytoskeleton remodeling, beta1 integrin clustering and increased cell adhesion to fibronectin through the Abl interactor 1 pathway. J. Cell Sci., 120, 1436-1446.
42. Courtney, K.D. et al. (2000) Localization and phosphorylation of Ablinteractor proteins, Abi-1 and Abi-2, in the developing nervous system. Mol. Cell. Neurosci., 16, 244-257.
43. Bowden, E.T. et al. (2001) Invadopodia: unique methods for measurement of extracellular matrix degradation in vitro. Methods Cell Biol., 63, 613-627.
44. Clark, E.S. et al. (2007) Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia. Cancer Res., 67, 4227-4235.
45. Chen, W.T. et al. (1994) Membrane proteases as potential diagnostic and therapeutic targets for breast malignancy. Breast Cancer Res. Treat., 31, 217-226.
46. Kelly, T. et al. (1998) Proteolysis of extracellular matrix by invadopodia facilitates human breast cancer cell invasion and is mediated by matrix metalloproteinases. Clin. Exp. Metastasis, 16, 501-512.
47. Bowden, E.T. et al. (1999) An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation. Oncogene, 18, 4440-4449.
48. Bowden, E.T. et al. (2006) Co-localization of cortactin and phosphotyrosine identifies active invadopodia in human breast cancer cells. Exp. Cell Res., 312, 1240-1253.
49. Kunda, P. et al. (2003) Abi, Sra1, and Kette control the stability and localization of SCAR/WAVE to regulate the formation of actin-based protrusions. Curr. Biol., 13, 1867-1875.
50. Olmeda, D. et al. (2007) SNAI1 is required for tumor growth and lymph node metastasis of human breast carcinoma MDA-MB-231 cells. Cancer Res., 67, 11721-11731.
51. Bergers, G. et al. (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol., 2, 737-744.